CRP apheresis at the Klinikum Havelhöhe shown in the rbb Abendschau
17.04.2021
COVID-19 patients are treated with CRP apheresis at the Klinikum Havelhöhe. This was featured in the rbb Abendschau.
IHK FORUM reports on CRP apheresis for COVID-19
30.03.2021
The Brandenburg business magazine FORUM reported on CRP apheresis in its April 2021 issue.
'European Hospital' reports of CRP apheresis in Covid-19
25.01.2021
The page 'Healthcare in Europe' reported about the recently successfully treated COVID-19 patient.
Report about COVID-19 patient, who was successfully treated with the PentraSorb®
20.01.2021
The Märkische Oderzeitung reported about a recently successfully treated COVID-19 patient. The patient was treated 4 times with CRP apheresis and is recovering rapidly from the disease. The article describes that the therapy most likely saved the patient from intensive care medical treatment.
Feature about CRP apheresis in the magazine rbb PRAXIS
13.01.2021
The use of CRP apheresis in COVID-19 patients was presented once again in the rbb PRAXIS magazine.
The feature reports the recent successful treatment of a COVID-19 patient with apheresis. In addition, Prof. Dr. Kielstein from the Braunschweig Clinic advocates for the therapy.
Report about Pentracor and CRP apheresis in the MOZ
01.12.2020
The Märkische Oder Zeitung reported about Pentracor GmbH and CRP apheresis as a therapy option for Covid-19 patients. The article briefly describes the company's history with all the challenges overcome so far as well as the possibility to help Corona patients.
Interview on the bond issue with the BondGuide
25.05.2020 - In an interview with the corporate bond portal BondGuide, company founder and CEO Ahmed Sheriff talks about the reasons for the bond issue and the company's business plan:
New issue of Pentracor: "We are the first and so far the only ones who have succeeded".
Interview on the bond issue with the Bond Finder
22.05.2020 - In an interview with the bond platform Bond Finder, company founder Ahmed Sheriff talks about the background to the bond issue and explains why going to the capital market is the next logical step in the company's development:
„Our medical device innovation is unrivalled" - Interview with Dr. Ahmed Sheriff, Pentracor GmbH
Interview on the bond issue with the stock exchange portal 4investors
22 May 2020 - In an interview with the stock market portal 4investors, Pentracor CEO Ahmed Sheriff and CFO Sven Haevernick explain their plans for the new bond, the future corporate goals and the global market potential of PentraSorb® CRP:
"Pentracor: IPO would be a logical step - FMC among investors"
The CRP apheresis was presented in the RBB magazine "Praxis"
15.04.2020
In the programme of 15 April 2020, CRP apheresis was presented as an option for the treatment of COVID-19. Furthermore, Professor Garlichs, Chief Physician of the Medical Clinic - Internal Medicine of the Diakonissenkrankenhaus in Flensburg, presented the results of the CAMI 1 study. The approx.
